血细胞淋巴细胞细胞瘤:我们是否有解决TMI (过多的炎症) 的方法?
Paul La Rosée1, Rafal Machowicz2
1Schwarzwald-Baar-Klinikum, Klinik für Innere Medizin II, Onkologie, Hämatologie, Immunologie, Infektiologie u. Palliativmedizin, Villingen-Schwenningen, Germany.
Hematology. American Society of Hematology. Education Program
|December 5, 2025
概括
血细胞淋巴细胞瘤 (HLH) 和相关疾病是严重的炎症状况. 早期诊断和向治疗对于改善HLH成年患者的生存率至关重要.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 关键护理医学 关键护理医学
背景情况:
- 血细胞淋巴细胞瘤 (HLH) 和相关疾病代表了过度炎症 (TMI) 的极端形式.
- 与血液恶性瘤相关的成人HLH具有较高的死亡率 (70-80%) 由于诊断延迟和并发症.
- 由于教育努力,流行病学转变和最近的治疗进展,诊断意识的提高受到推动.
研究的目的:
- 突出诊断和管理HLH和成人相关综合征的挑战.
- 讨论最近的进展对HLH临床实践的影响.
- 强调HLH从被忽视的领域转变为成人血液学中最重要的话题.
主要方法:
- 审查最近在HLH诊断和治疗方面的进展.
- 讨论影响诊断意识的流行病学因素.
- 分析新的预后模型和治疗策略.
主要成果:
- 提高了诊断意识和早期识别HLH.
- 引入向疗法,包括抗干扰素马抗体.
- 管理相关疾病的进展,如移植对宿主疾病.
结论:
- 高血压和相关综合征是关键的条件,需要及时诊断和管理.
- 个性化,细胞因子导向的疗法提供了更好的结果.
- 这些具有挑战性的实体现在是成年人血液学实践的核心焦点.
相关概念视频
Regulation of Hematopoietic Stem Cells
3.9K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.9K
Inflammatory Response
15.9K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
15.9K
Inflammatory Response II: Inflammatory Exudate and Tissue Repair
7.3K
The immune system's inflammatory response destroys the invading pathogen, permitting the tissue to heal. The changes during the cellular and vascular stages allow exudate formation at the site of inflammation. The inflammatory exudate released from the wound has high protein content and a specific gravity above 1.020.
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
7.3K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Role of Hematopoietic Growth Factors
3.1K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
3.1K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
457
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
457


